ADP®, a leading provider of human resource outsourcing, payroll, tax, business outsourcing and benefits administration services, and integrated computing solutions for vehicle dealers, today announced the launch of ALINE Pay by ADPSM, a comprehensive electronic payroll disbursement solution that helps employers reduce administration time and minimize their risk of financial and compliance exposure. The ALINE Pay electronic pay solution is designed to be compliant in all 50 states through a new innovative wage funding and distribution solution and gives both employers and employees flexibility in choosing the method of payment that best meets their needs: ADP Full Service Direct Deposit, the new ALINE Card by ADPSM or ALINE Check by ADPSM.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51192-adp-aline-pay-electronic-payroll-compliance-solution
Nine out of ten parents believe there is a “father absence crisis” in America, according to two national surveys by the National Fatherhood Initiative. To inspire fathers to become more involved in the lives of their children, the U.S. Department of Health and Human Services’ Administration for Children and Families, Office of Family Assistance, the National Responsible Fatherhood Clearinghouse (NRFC) and The Advertising Council are launching a new series of public service advertisements (PSAs).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/46540/
Allergan, Inc. (NYSE: AGN), the makers of LATISSE® (bimatoprost ophthalmic solution) 0.03%, announced today the launch of the LATISSE® Wishes Challenge campaign. Inspired by the tradition of blowing on an eyelash to make wishes come true, lifestyle designer Kathy Ireland, professional ballroom dancer Chelsie Hightower and style guide Bobbie Thomas will each lead teams of LATISSE® users from across the country who are challenged to raise more than a quarter of a million dollars for the Make-A-Wish Foundation, a nonprofit organization dedicated to granting the wishes of children with life-threatening medical conditions. LATISSE® solution is the first and only prescription treatment approved by the U.S. Food and Drug Administration (FDA) to grow lashes longer, fuller and darker for those with inadequate or not enough lashes (eyelash hypotrichosis).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/latisse/43354/
The Substance Abuse and Mental Health Services Administration (SAMHSA) in collaboration with the Ad Council today expanded efforts to continue to provide information, support and resources to individuals and families affected by the Deepwater Horizon oil spill. Emotional distress resulting from traumatic events can surface years after an incident occurs.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/48177/
Actress and Screenwriter of “My Big Fat Greek Wedding” Nia Vardalos joins the U.S. Department of Health and Human Services’ (HHS) Administration for Children and Families (ACF), AdoptUsKids (AUsK) and the Ad Council today to unveil a new series of national public service advertisements (PSAs) designed to encourage the adoption of biological siblings from the U.S. foster care system. The PSAs are being distributed this week as part of National Adoption Month.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/46953/
The Substance Abuse and Mental Health Services Administration (SAMHSA), working in collaboration with the Ad Council and the Inspire USA Foundation, announced today the launch of a national public service announcement campaign designed to reduce the incidence of suicide and suicide attempts among teens in the United States.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/43256/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
One thousand women die daily due to pregnancy related causes and the majority of Americans (75%) believe that reducing these deaths should be a priority of President Obama and his Administration, according to a study just released by Americans for UNFPA, conducted by Harris Interactive². Further, over eight in ten agree that lack of adequate healthcare is one of the most serious global issues facing women (82%).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/harrisinteractive/44730/
The National Credit Union Administration (NCUA) today announced the launch of a new national campaign designed to educate consumers about the benefits and purpose of the National Credit Union Share Insurance Fund (NCUSIF), the federal fund which insures member deposits in federally insured credit unions. The
“The smallest moments can have the biggest impact on a child’s life. Take time to be a dad today.” That’s the campaign message of new public service advertisements (PSAs) launching today nationwide in recognition of Father’s Day. According to the U.S. Census Bureau, an estimated 24 million children (34%) in the U.S. live apart from their fathers. The PSA campaign is an effort between the U.S. Department of Health and Human Services’ (HHS) Administration for Children and Families, Office of Family Assistance and the Ad Council to show fathers the unique and irreplaceable role they play in their children’s lives.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/50580/
Gen-Probe (NASDAQ: GPRO) announced today the US Food and Drug Administration (FDA) has approved its PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53530-gen-probe-progensa-pca3-prostate-cancer-psa